Daiichi Sankyo

Results: 304



#Item
1April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

Add to Reading List

Source URL: www.dcat.org

Language: English - Date: 2016-04-07 10:30:28
2benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b

benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b

Add to Reading List

Source URL: milfordk12.org

Language: English
3May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese

May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese

Add to Reading List

Source URL: www.dcat.org

Language: English - Date: 2016-05-13 09:47:23
4Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich

Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2016-05-30 21:34:45
    5For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University,

    For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University,

    Add to Reading List

    Source URL: www.daiichisankyo.com

    Language: English - Date: 2016-04-14 01:21:57
      6For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

      For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

      Add to Reading List

      Source URL: www.daiichisankyo.com

      Language: English - Date: 2016-04-18 01:10:20
        7For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries

        For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries

        Add to Reading List

        Source URL: www.daiichisankyo.com

        Language: English - Date: 2016-05-11 04:43:58
          8For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

          For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

          Add to Reading List

          Source URL: www.daiichisankyo.com

          Language: English - Date: 2016-05-11 06:06:42
            9For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

            For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquirie

            Add to Reading List

            Source URL: www.daiichisankyo.com

            Language: English - Date: 2016-05-24 20:52:07
              10Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation

              Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation

              Add to Reading List

              Source URL: www.daiichisankyo.com

              Language: English - Date: 2016-05-20 07:19:52